1. Academic Validation
  2. IL-18/IL-18BP and IL-22/IL-22BP: Two interrelated couples with therapeutic potential

IL-18/IL-18BP and IL-22/IL-22BP: Two interrelated couples with therapeutic potential

  • Cell Signal. 2019 Nov:63:109388. doi: 10.1016/j.cellsig.2019.109388.
Heiko Mühl 1 Malte Bachmann 2
Affiliations

Affiliations

  • 1 pharmazentrum frankfurt/ZAFES, University Hospital Goethe University Frankfurt am Main, Theodor-Stern- Kai 7, 60590 Frankfurt am Main, Germany. Electronic address: [email protected].
  • 2 pharmazentrum frankfurt/ZAFES, University Hospital Goethe University Frankfurt am Main, Theodor-Stern- Kai 7, 60590 Frankfurt am Main, Germany.
Abstract

Interleukin (IL)-18 and IL-22 are key components of cytokine networks that play a decisive role in (pathological) inflammation, host defense, and tissue regeneration. Tight regulation of cytokine-driven signaling, inflammation, and immunoactivation is supposed to enable nullification of a given deleterious trigger without mediating overwhelming collateral tissue damage or even activating a cancerous face of regeneration. In fact, feedback regulation by specific cytokine opponents is regarded as a major means by which the immune system is kept in balance. Herein, we shine a light on the interplay between IL-18 and IL-22 and their opponents IL-18 binding protein (IL-18BP) and IL-22BP in order to provide integrated information on their biology, pathophysiological significance, and prospect as targets and/or instruments of therapeutic intervention.

Keywords

Cytokines; Inflammation; Interleukin-18; Interleukin-18 binding protein; Interleukin-22; Interleukin-22 binding protein.

Figures